OVERVIEW
We advise a diverse clientele (including both domestic and international ones) in respect of mergers and acquisitions, joint ventures and takeovers across various business segments. We have extensive experience in representing clients to undertake M&As involving listed entities and in that process also support the board and independent directors of listed companies. In addition, we also provide comprehensive guidance with regard to corporate governance and complex regulatory issues.
We are committed to provide full-spectrum assistance and one-stop solution to our clients throughout the entire lifecycle of the transaction right from its structuring until closing of the transaction. For providing comprehensive legal services, our Corporate and M&A team also closely works with other teams within the Firm including the tax team and Regulatory team to provide structuring and tax advise; Insolvency & Restructuring team to support clients in distressed M&As; Competition team and Employment team to advise on specialized areas; and Litigation team on critical matters which give rise to potential dispute/liability.
TESTIMONIALS
“We go to them for complex regulatory matters – their word is generally the last word on regulations and is backed up by government views and practice.”
“Saraf and Partners is a firm with a strong experience base and good market sense.”
“The team has in-depth knowledge of regulations, with insightful and practical solutions developed from extensive experience of having worked in this space.”
“The team has really good extensive knowledge of the complex issues around M&A, particularly for the Dotcom domain for which we consulted them.”
KEY PARTNERS
-
Advised Vedanta Group to set up a joint venture with Foxconn, for manufacturing semi-conductors in India with capital outlay of over USD 20 billion, in one of the biggest joint venture deals in India.
-
Advised Viatris (formerly, Mylan) in the sale of its global biosimilar business to Biocon Biologics (a subsidiary of Biocon) for USD 3.335 billion. This deal is the largest M&A deal in India in biosimilars business and one of the largest M&A deals in India in pharmaceutical space. Awards: (i) M&A Deal of the Year (Premium) at the Asian Legal Business (ALB) India Law Awards 2023; and (ii) India Business Law Journal (IBLJ) Deal of the Year 2022.
-
Advised Government of India through Department of Investment and Public Asset Management, Ministry of Finance (DIPAM), on the disinvestment of Neelanchal Ispat Nigam Limited to Tata Steel Long Products Limited (Buyer), a listed company and a subsidiary of Tata Steel Limited, in a deal valued at USD 1.48 billion.
-
Advised Zomato in respect of its 100% acquisition of Blinkit (formerly, Grofers) (India’s leading online grocery delivery provider) in a deal valued at USD 575 million. This deal is the largest M&A deal in India in the quick e-commerce space.
-
Advised Fortis Healthcare in bid process concluding with IHH Healthcare acquiring Fortis Healthcare for a deal value of over USD 1.1 billion – in the largest ever takeover deal in the Indian healthcare space.
-
Advised Tata Advanced Systems for setting up a 51:49 Indian joint venture with Boeing, with the goal of manufacturing and supplying airplanes for US military and the Indian Ministry of Defence.